MedPath

Clinical Trial to Evaluate the Effect of an Oral Probiotic on the Vaginal Flora

Not Applicable
Completed
Conditions
Vaginal Flora
Registration Number
NCT03923985
Lead Sponsor
Instituto Palacios
Brief Summary

Clinical trial to evaluate the effect of a probiotic containing Lactobacillus Crispatus on the vaginal flora

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Healthy women between 18 and 45 years old
  • Women without current symptoms of vaginal infection
  • Negative bacteriological and clinical examination
Exclusion Criteria
  • Women with vaginal infection
  • Women with undiagnosed vaginal bleeding
  • Patients with endometrial hyperplasia
  • Suspicion of neoplasia or active neoplasia
  • Women with intolerance, allergy or hypersensitivity to the components of the probiotic
  • Women with immunosuppressive disorders or with HIV
  • Women who are currently using probiotics by any route of administration
  • Women who are using some treatment for vaginal sepsis
  • Chronic decompensated noncommunicable diseases (diabetes mellitus, heart disease ...)
  • Pregnant women or those with precocious menopause

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in the number of Lactobacillus Crispatus on the vaginal floraScreening, month 2

Analysis of vaginal lactobacilli.

Secondary Outcome Measures
NameTimeMethod
Changes in vaginal PHScreening, month 2

PH measurement

Trial Locations

Locations (1)

Instituto Palacios

🇪🇸

Madrid, Spain

Instituto Palacios
🇪🇸Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.